8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
May 4, 2026·SEC
Material company update
Apr 15, 2026·SEC
Ingevity Corporation(NGVT)Earnings, Financials & Key Ratios
NGVT•NYSE
Price updated Jun 13, 2026
AboutIngevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.Show more
- Revenue$1.17B-17.0%
- EBITDA$368M
- Net Income-$167M+61.2%
- EPS (Diluted)-4.61+61.1%
- Gross Margin39.53%+22.3%
- EBITDA Margin31.54%+20.5%
- Operating Margin22.43%+21.4%
- Net Margin-14.31%+53.2%
- ROE-148.6%-42.7%
- ROIC14.15%+32.6%
- Debt/Equity41.84+461.5%
- Interest Coverage-0.94+78.9%
NGVT Key Insights
Ingevity Corporation (NGVT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FCF machine: 23.4% free cash flow margin
✗Weaknesses
- ✗High debt to equity ratio of 41.8x
- ✗Expensive at 87.7x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when NGVT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NGVT Price & Volume
Ingevity Corporation (NGVT) stock price & volume — 10-year historical chart
Loading chart...
NGVT Growth Metrics
Ingevity Corporation (NGVT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years1.89%
5 Years-0.81%
3 Years-11.21%
TTM-10.29%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM63.88%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM63.59%
Return on Capital
10 Years18.85%
5 Years13.98%
3 Years13.64%
Last Year17.07%
NGVT Recent Earnings
Ingevity Corporation (NGVT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 6, 2026EPS
$1.15
Est $0.84
+36.9%
Revenue
$258M
Est $255M
+1.3%
Q1 2026
Feb 25, 2026EPS
$0.58
Est $0.67
-12.8%
Revenue
$255M
Est $257M
-0.8%
Q4 2025
Nov 5, 2025EPS
$1.31
Est $0.68
+92.6%
Revenue
$333M
Est $257M
+29.5%
Q3 2025
Aug 4, 2025EPS
$1.39
Est $1.02
+36.3%
Revenue
$365M
Est $372M
-1.9%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $1.15vs $0.84+36.9% | $258Mvs $255M+1.3% |
| Q1 2026 | Feb 25, 2026 | $0.58vs $0.67-12.8% | $255Mvs $257M-0.8% |
| Q4 2025 | Nov 5, 2025 | $1.31vs $0.68+92.6% | $333Mvs $257M+29.5% |
| Q3 2025 | Aug 4, 2025 | $1.39vs $1.02+36.3% | $365Mvs $372M-1.9% |
Based on last 12 quarters of dataView full earnings history →
NGVT Peer Comparison
Ingevity Corporation (NGVT) competitors in Carbon and activated carbon materials — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 FUL | 3.45B | 63.63 | 23.14 | -2.67% | 4.38% | 7.59% | 1.01 | |
 IOSP | 2.13B | 86.59 | 18.54 | -3.65% | 6.38% | 8.64% | 0.07 | |
 KWR | 2.5B | 144.46 | -1031.86 | 2.66% | 0.22% | 0.31% | 0.67 | |
 CBT | 4.58B | 87.65 | 14.56 | -7.04% | 7.97% | 16.75% | 0.71 | |
 ASIX | 614.93M | 22.81 | 12.67 | 0.31% | 0.67% | 1.28% | 0.47 | |
 HWKN | 3.3B | 158.34 | 40.50 | 11.21% | 7.52% | 15.96% | 0.49 | |
 ECL | 74.96B | 265.41 | 36.46 | 2.16% | 12.91% | 21.96% | 0.96 | |
 RPM | 13.71B | 107.05 | 20.01 | 0.51% | 8.79% | 21.29% | 1.03 |
Compare NGVT vs Peers
Ingevity Corporation (NGVT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NGVT Income Statement
Ingevity Corporation (NGVT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 972.4M | 1.13B | 1.29B | 1.22B | 1.39B | 1.67B | 1.69B | 1.41B | 1.17B | 1.21B |
Revenue Growth % | 7.06% | 16.58% | 14.05% | -5.94% | 14.42% | 19.89% | 1.43% | -16.88% | -16.98% | -10.29% |
Cost of Goods Sold | 643.4M | 716.8M | 810.9M | 750.6M | 878.7M | 1.1B | 1.22B | 951.7M | 706.1M | 735.3M |
COGS % of Revenue | 66.17% | 63.23% | 62.72% | 61.72% | 63.15% | 65.83% | 72.11% | 67.67% | 60.47% | - |
Gross Profit | 329M▲ 0% | 416.8M▲ 26.7% | 482M▲ 15.6% | 465.5M▼ 3.4% | 512.8M▲ 10.2% | 570.1M▲ 11.2% | 471.9M▼ 17.2% | 454.7M▼ 3.6% | 461.5M▲ 1.5% | 476M▲ 0% |
Gross Margin % | 33.83% | 36.77% | 37.28% | 38.28% | 36.85% | 34.17% | 27.89% | 32.33% | 39.53% | 39.3% |
Gross Profit Growth % | 19.9% | 26.69% | 15.64% | -3.42% | 10.16% | 11.17% | -17.22% | -3.64% | 1.5% | - |
Operating Expenses | 126.2M | 153.9M | 182.8M | 465.5M | 205.6M | 229.1M | 215.5M | 194.8M | 199.6M | 199.5M |
OpEx % of Revenue | 12.98% | 13.58% | 14.14% | 38.28% | 14.78% | 13.73% | 12.74% | 13.85% | 17.09% | - |
Selling, General & Admin | 106.4M | 132.4M | 163.1M | 149.4M | 179.3M | 198.8M | 183.7M | 166.7M | 171.2M | 170.6M |
SG&A % of Revenue | 10.94% | 11.68% | 12.62% | 12.29% | 12.89% | 11.92% | 10.86% | 11.85% | 14.66% | - |
Research & Development | 19.8M | 21.5M | 19.7M | 22.6M | 26.3M | 30.3M | 31.8M | 28.1M | 28.4M | 28.9M |
R&D % of Revenue | 2.04% | 1.9% | 1.52% | 1.86% | 1.89% | 1.82% | 1.88% | 2% | 2.43% | - |
Other Operating Expenses | -500K | -1M | 0 | 293.5M | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 202.8M▲ 0% | 262.9M▲ 29.6% | 327.9M▲ 24.7% | 0▼ 100.0% | 307.2M▲ 0% | 341M▲ 11.0% | 256.4M▼ 24.8% | 259.9M▲ 1.4% | 261.9M▲ 0.8% | 276.5M▲ 0% |
Operating Margin % | 20.86% | 23.19% | 25.36% | - | 22.08% | 20.44% | 15.15% | 18.48% | 22.43% | 22.83% |
Operating Income Growth % | 26.43% | 29.64% | 24.72% | -100% | - | 11% | -24.81% | 1.37% | 0.77% | - |
EBITDA | 243.2M | 319.9M | 412.9M | 382.4M | 417.1M | 449.8M | 379.2M | 368.2M | 368.3M | 378.2M |
EBITDA Margin % | 25.01% | 28.22% | 31.94% | 31.44% | 29.97% | 26.96% | 22.41% | 26.18% | 31.54% | 31.22% |
EBITDA Growth % | 22.09% | 31.54% | 29.07% | -7.39% | 9.07% | 7.84% | -15.7% | -2.9% | 0.03% | -0.58% |
D&A (Non-Cash Add-back) | 40.4M | 57M | 85M | 100.2M | 109.9M | 108.8M | 122.8M | 108.3M | 106.4M | 101.7M |
EBIT | 202.7M | 262.8M | 283.7M | 282.2M | 214.5M | 331.4M | 83.2M | -437.8M | -69M | -61.7M |
Net Interest Income | -15.8M | -29.8M | -46.9M | -42.2M | -47.7M | -56M | -87M | -90.9M | -73.1M | -69.6M |
Interest Income | 2.3M | 3.4M | 8.9M | 4.9M | 4M | 5.8M | 6.3M | 6.9M | 0 | 2.1M |
Interest Expense | 18.1M | 33.2M | 55.8M | 47.1M | 51.7M | 61.8M | 93.3M | 97.8M | 73.1M | 71.7M |
Other Income/Expense | -28M | -41.1M | -71.3M | 235.1M | -144.4M | -71.4M | -266.5M | -795.5M | -404M | -432.1M |
Pretax Income | 174.8M▲ 0% | 221.8M▲ 26.9% | 227.9M▲ 2.8% | 235.1M▲ 3.2% | 162.8M▼ 30.8% | 269.6M▲ 65.6% | -10.1M▼ 103.7% | -535.6M▼ 5203.0% | -142.1M▲ 73.5% | -155.6M▲ 0% |
Pretax Margin % | 17.98% | 19.57% | 17.63% | 19.33% | 11.7% | 16.16% | -0.6% | -38.08% | -12.17% | -12.85% |
Income Tax | 29.8M | 40M | 44.2M | 53.7M | 44.7M | 58M | -4.7M | -105.3M | 8.2M | 5.5M |
Effective Tax Rate % | 17.05% | 18.03% | 19.39% | 22.84% | 27.46% | 21.51% | 46.53% | 19.66% | -5.77% | -3.53% |
Net Income | 126.3M▲ 0% | 169.1M▲ 33.9% | 183.7M▲ 8.6% | 181.4M▼ 1.3% | 118.1M▼ 34.9% | 211.6M▲ 79.2% | -5.4M▼ 102.6% | -430.3M▼ 7868.5% | -167.1M▲ 61.2% | -127.8M▲ 0% |
Net Margin % | 12.99% | 14.92% | 14.21% | 14.92% | 8.49% | 12.68% | -0.32% | -30.6% | -14.31% | -10.55% |
Net Income Growth % | 258.81% | 33.89% | 8.63% | -1.25% | -34.9% | 79.17% | -102.55% | -7868.52% | 61.17% | 63.88% |
Net Income (Continuing) | 145.2M | 181.8M | 183.7M | 181.4M | 118.1M | 211.6M | -5.4M | -430.3M | -150.3M | -161.1M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.8M | 1000K |
Minority Interest | 14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 2.97▲ 0% | 3.97▲ 33.7% | 4.35▲ 9.6% | 4.37▲ 0.5% | 2.95▼ 32.5% | 5.50▲ 86.4% | -0.15▼ 102.7% | -11.85▼ 7800.0% | -4.61▲ 61.1% | -3.55▲ 0% |
EPS Growth % | 257.83% | 33.67% | 9.57% | 0.46% | -32.49% | 86.44% | -102.73% | -7800% | 61.1% | 63.59% |
EPS (Basic) | 3.00 | 4.03 | 4.39 | 4.39 | 2.97 | 5.54 | -0.15 | -11.85 | -4.61 | - |
Diluted Shares Outstanding | 42.5M | 42.6M | 42.2M | 41.55M | 40.06M | 38.47M | 36.5M | 36.32M | 36.2M | 36M |
Basic Shares Outstanding | 42.1M | 42M | 41.8M | 41.3M | 39.8M | 38.47M | 36.5M | 36.32M | 36.2M | 35.3M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
NGVT Balance Sheet
Ingevity Corporation (NGVT) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 369.3M | 422.7M | 463.2M | 628.7M | 724.9M | 683.3M | 658.6M | 493.2M | 391.3M | 581.8M |
Cash & Short-Term Investments | 87.9M | 77.5M | 56.5M | 257.7M | 275.4M | 76.7M | 95.9M | 68M | 78.1M | 180.5M |
Cash Only | 87.9M | 77.5M | 56.5M | 257.7M | 275.4M | 76.7M | 95.9M | 68M | 78.1M | 95.4M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 85.1M |
Accounts Receivable | 102.4M | 124M | 156.2M | 166.7M | 191.4M | 249.3M | 211M | 172M | 127.2M | 151.2M |
Days Sales Outstanding | 38.44 | 39.93 | 44.1 | 50.03 | 50.21 | 54.54 | 45.51 | 44.64 | 39.76 | 48.76 |
Inventory | 160M | 191.4M | 212.5M | 189M | 241.2M | 335M | 308.8M | 226.8M | 186M | 203.6M |
Days Inventory Outstanding | 90.77 | 97.46 | 95.65 | 91.91 | 100.19 | 111.34 | 92.37 | 86.98 | 96.15 | 99.73 |
Other Current Assets | 16.9M | 26.6M | 34.6M | 6.8M | 7.1M | 12.5M | 33.4M | 18.2M | 0 | 46.5M |
Total Non-Current Assets | 561M | 892.5M | 1.68B | 1.71B | 1.74B | 2.05B | 1.96B | 1.53B | 871.6M | 1.07B |
Property, Plant & Equipment | 438.5M | 523.8M | 664.7M | 752.7M | 772.1M | 855.2M | 829.3M | 709.3M | 608.1M | 599.8M |
Fixed Asset Turnover | 2.22x | 2.16x | 1.95x | 1.62x | 1.80x | 1.95x | 2.04x | 1.98x | 1.92x | 1.89x |
Goodwill | 12.4M | 130.7M | 439M | 445.3M | 442M | 518.5M | 527.5M | 175.2M | 4.3M | 4.3M |
Intangible Assets | 23.4M | 125.6M | 396.2M | 397.3M | 378.7M | 455.8M | 385.3M | 323.9M | 176.1M | 168M |
Long-Term Investments | 71.3M | 71.2M | 72.6M | 0 | 35.3M | 109.8M | 99.2M | 87.3M | 83.1M | 356.5M |
Other Non-Current Assets | 12M | 38.3M | 103.7M | 102.4M | 109.2M | 108.2M | 111.8M | 115.2M | -117M | 112.7M |
Total Assets | 930.3M▲ 0% | 1.32B▲ 41.4% | 2.14B▲ 63.0% | 2.33B▲ 8.9% | 2.47B▲ 5.8% | 2.74B▲ 10.8% | 2.62B▼ 4.1% | 2.02B▼ 22.9% | 1.65B▼ 18.4% | 1.65B▲ 0% |
Asset Turnover | 1.05x | 0.86x | 0.60x | 0.52x | 0.56x | 0.61x | 0.65x | 0.70x | 0.71x | 0.69x |
Asset Growth % | 11.71% | 41.37% | 63.05% | 8.87% | 5.76% | 10.83% | -4.14% | -22.9% | -18.37% | -72.7% |
Total Current Liabilities | 154M | 183.3M | 215.5M | 223.4M | 268.9M | 303.5M | 362.9M | 264.1M | 341.3M | 409.4M |
Accounts Payable | 83.1M | 92.9M | 99.1M | 104.2M | 125.8M | 174.8M | 158.4M | 94.5M | 92M | 85M |
Days Payables Outstanding | 47.14 | 47.31 | 44.61 | 50.67 | 52.26 | 58.1 | 47.38 | 36.24 | 47.56 | 47.08 |
Short-Term Debt | 9.4M | 11.2M | 39.6M | 26M | 19.6M | 900K | 84.4M | 61.3M | 58.9M | 121.9M |
Deferred Revenue (Current) | 10.6M | 25.5M | -6.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 21.5M | 37.2M | 16.2M | 1.1M | 1.1M | 6.9M | 15.1M | 500K | 190.4M | 202.5M |
Current Ratio | 2.40x | 2.31x | 2.15x | 2.81x | 2.70x | 2.25x | 1.81x | 1.87x | 1.15x | 1.42x |
Quick Ratio | 1.36x | 1.26x | 1.16x | 1.97x | 1.80x | 1.15x | 0.96x | 1.01x | 0.60x | 0.92x |
Cash Conversion Cycle | 82.06 | 90.08 | 95.14 | 91.27 | 98.14 | 107.79 | 90.5 | 95.38 | 88.35 | 101.41 |
Total Non-Current Liabilities | 498.6M | 792.3M | 1.4B | 1.47B | 1.53B | 1.73B | 1.63B | 1.56B | 1.28B | 1.2B |
Long-Term Debt | 444M | 741.2M | 1.15B | 1.27B | 1.25B | 1.47B | 1.38B | 1.24B | 1.06B | 1.08B |
Capital Lease Obligations | 80M | 73.9M | 36.7M | 34.7M | 36.2M | 40.8M | 48.6M | 135.7M | 120M | 270.5M |
Deferred Tax Liabilities | 41.3M | 37.2M | 103M | 117M | 114.6M | 106.5M | 70.9M | 56.2M | 57.3M | 167.7M |
Other Non-Current Liabilities | -66.8M | -59.1M | 109.9M | 49.9M | 125.5M | 114.9M | 126.7M | 130.6M | 39M | 66.2M |
Total Liabilities | 652.6M | 975.6M | 1.61B | 1.69B | 1.8B | 2.04B | 1.99B | 1.83B | 1.62B | 1.61B |
Total Debt | 444M | 741.2M | 1.23B | 1.34B | 1.32B | 1.53B | 1.53B | 1.45B | 1.24B | 1.2B |
Net Debt | 356.1M | 663.7M | 1.17B | 1.09B | 1.05B | 1.45B | 1.44B | 1.39B | 1.16B | 1.11B |
Debt / Equity | 1.52x | 2.18x | 2.31x | 2.09x | 1.96x | 2.19x | 2.43x | 7.45x | 41.84x | 30.96x |
Debt / EBITDA | 1.83x | 2.32x | 2.98x | 3.52x | 3.17x | 3.40x | 4.05x | 3.95x | 3.37x | 3.18x |
Net Debt / EBITDA | 1.46x | 2.07x | 2.84x | 2.84x | 2.51x | 3.23x | 3.79x | 3.77x | 3.16x | 2.93x |
Interest Coverage | 11.20x | 7.92x | 5.08x | 5.99x | 4.15x | 5.36x | 0.89x | -4.48x | -0.94x | -0.86x |
Total Equity | 291.7M▲ 0% | 339.6M▲ 16.4% | 530.8M▲ 56.3% | 642.1M▲ 21.0% | 673.8M▲ 4.9% | 698.3M▲ 3.6% | 631.4M▼ 9.6% | 195.2M▼ 69.1% | 29.7M▼ 84.8% | 38.9M▲ 0% |
Equity Growth % | 105.13% | 16.42% | 56.3% | 20.97% | 4.94% | 3.64% | -9.58% | -69.08% | -84.78% | -261.44% |
Book Value per Share | 6.86 | 7.97 | 12.58 | 15.45 | 16.82 | 18.15 | 17.30 | 5.37 | 0.82 | 1.08 |
Total Shareholders' Equity | 277.7M | 339.6M | 530.8M | 642.1M | 673.8M | 698.3M | 631.4M | 195.2M | 29.7M | 38.9M |
Common Stock | 400K | 400K | 400K | 400K | 400K | 400K | 400K | 400K | 400K | 0 |
Retained Earnings | 142.8M | 313.5M | 497.2M | 678M | 796.1M | 1.01B | 1B | 572M | 404.9M | 0 |
Treasury Stock | -7.7M | -55.8M | -74.6M | -162.3M | -272.1M | -416M | -509.5M | -512.6M | -571.8M | 0 |
Accumulated OCI | -11.7M | -17.7M | -5M | 4.7M | 13.1M | -46.8M | -26.7M | -41.4M | 500K | 0 |
Minority Interest | 14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NGVT Cash Flow Statement
Ingevity Corporation (NGVT) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 174.3M | 252M | 275.7M | 352.4M | 293.3M | 313.4M | 205.1M | 128.6M | 331.2M | 303.8M |
Operating CF Margin % | 17.92% | 22.23% | 21.32% | 28.98% | 21.08% | 18.79% | 12.12% | 9.14% | 28.37% | - |
Operating CF Growth % | 36.28% | 44.58% | 9.4% | 27.82% | -16.77% | 6.85% | -34.56% | -37.3% | 157.54% | 287.59% |
Net Income | 145.2M | 181.8M | 183.7M | 181.4M | 118.1M | 211.6M | -5.4M | -430.3M | -167.1M | -127.8M |
Depreciation & Amortization | 40.4M | 57M | 85M | 100.2M | 109.9M | 108.8M | 122.8M | 108.3M | 106.4M | 104.1M |
Stock-Based Compensation | 10.1M | 12.5M | 12.3M | 8.4M | 12.3M | 16.1M | 10.6M | 11.9M | 1.4M | 5.2M |
Deferred Taxes | -25.7M | 900K | 14.8M | 16.2M | -4.6M | -5M | -44.7M | -121.4M | 0 | 21.8M |
Other Non-Cash Items | 7.6M | 9.5M | 13.1M | 34.4M | 27.1M | 48.4M | 262.5M | 560.3M | 375.5M | 367.2M |
Working Capital Changes | -3.3M | -9.7M | -33.2M | 11.8M | 30.5M | -66.5M | -140.7M | -200K | 15M | -27.6M |
Change in Receivables | -9.5M | -3M | -15.3M | 2.8M | -13.8M | -42.1M | 42.7M | 38.2M | 12.2M | 33.5M |
Change in Inventory | -6.6M | -26.9M | 500K | 22.3M | -55.8M | -63.7M | -75.6M | 86.2M | 40.2M | 53.4M |
Change in Payables | 1.7M | 5.7M | -6.2M | 9.4M | 14.8M | 42.7M | -14.6M | -63.4M | -2.6M | -10.6M |
Cash from Investing | -58.6M | -414.4M | -658.3M | -110.6M | -138.6M | -551.9M | -77.3M | -79.5M | -57.5M | 60.3M |
Capital Expenditures | -52.6M | -93.9M | -114.8M | -23.8M | -103.8M | -142.5M | -109.8M | -77.6M | -57.7M | -58M |
CapEx % of Revenue | 5.41% | 8.28% | 8.88% | 1.96% | 7.46% | 8.54% | 6.49% | 5.52% | 4.94% | 4.79% |
Acquisitions | 0 | -315.5M | -537.9M | 0 | 0 | -344.5M | 0 | 0 | 0 | 93.1M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -3M | -4.1M | -118.4M | -86.8M | 500K | -2.2M | 3.4M | -1.6M | 16.6M | 20.5M |
Cash from Financing | -57.8M | 153.7M | 369.2M | -50.2M | -133.1M | 48.1M | -99.9M | -70.2M | -252.2M | -303M |
Debt Issued (Net) | -38.2M | 303.9M | 385.9M | 48.4M | -26M | 199M | -7.3M | -67.1M | -193.6M | -193.7M |
Equity Issued (Net) | -7.8M | -49.9M | -20.7M | -88M | -109.4M | -145.2M | -92.1M | 0 | -54.9M | -107.2M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -6.6M | -47.4M | -6.4M | -88M | -109.4M | -145.2M | -92.1M | 0 | -56.3M | -108.6M |
Other Financing | -11.8M | -100.3M | 4M | -10.6M | 2.3M | -5.7M | -500K | -3.1M | -3.7M | -2.1M |
Net Change in Cash | 57.4M▲ 0% | -10.1M▼ 117.6% | -13.2M▼ 30.7% | 193.8M▲ 1568.2% | 19.9M▼ 89.7% | -196.4M▼ 1086.9% | 27.6M▲ 114.1% | -25.3M▼ 191.7% | 26M▲ 202.8% | 38.5M▲ 0% |
Free Cash Flow | 121.7M▲ 0% | 158.1M▲ 29.9% | 160.9M▲ 1.8% | 246.5M▲ 53.2% | 189.5M▼ 23.1% | 170.9M▼ 9.8% | 95.3M▼ 44.2% | 51M▼ 46.5% | 273.5M▲ 436.3% | 245.8M▲ 0% |
FCF Margin % | 12.52% | 13.95% | 12.44% | 20.27% | 13.62% | 10.24% | 5.63% | 3.63% | 23.42% | 20.29% |
FCF Growth % | 70.93% | 29.91% | 1.77% | 53.2% | -23.12% | -9.82% | -44.24% | -46.48% | 436.27% | 158.46% |
FCF per Share | 2.86 | 3.71 | 3.81 | 5.93 | 4.73 | 4.44 | 2.61 | 1.40 | 7.56 | 6.83 |
FCF Conversion (FCF/Net Income) | 1.38x | 1.49x | 1.50x | 1.94x | 2.48x | 1.48x | -37.98x | -0.30x | -1.98x | -1.92x |
Interest Paid | 16M | 26M | 48M | 39.6M | 47.5M | 54.8M | 82.7M | 85.4M | 0 | 42.3M |
Taxes Paid | 61.9M | 34.8M | 14.9M | 46.6M | 53.7M | 54.8M | 29.7M | 26.9M | 0 | 2.8M |
NGVT Key Ratios
Ingevity Corporation (NGVT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 58.22% | 53.57% | 42.21% | 30.93% | 17.95% | 30.84% | -0.81% | -104.11% | -148.6% | -156.14% |
| Return on Invested Capital (ROIC) | 24.52% | 23.88% | 18.18% | - | 13.36% | 13.2% | 9.11% | 10.68% | 14.15% | 16.24% |
| Gross Margin | 33.83% | 36.77% | 37.28% | 38.28% | 36.85% | 34.17% | 27.89% | 32.33% | 39.53% | 39.3% |
| Net Margin | 12.99% | 14.92% | 14.21% | 14.92% | 8.49% | 12.68% | -0.32% | -30.6% | -14.31% | -10.55% |
| Debt / Equity | 1.52x | 2.18x | 2.31x | 2.09x | 1.96x | 2.19x | 2.43x | 7.45x | 41.84x | 30.96x |
| Interest Coverage | 11.20x | 7.92x | 5.08x | 5.99x | 4.15x | 5.36x | 0.89x | -4.48x | -0.94x | -0.86x |
| FCF Conversion | 1.38x | 1.49x | 1.50x | 1.94x | 2.48x | 1.48x | -37.98x | -0.30x | -1.98x | -1.92x |
| Revenue Growth | 7.06% | 16.58% | 14.05% | -5.94% | 14.42% | 19.89% | 1.43% | -16.88% | -16.98% | -10.29% |
Related:NGVT Dividend History·NGVT Revenue History·NGVT Price History·NGVT P/E History·NGVT Financial Ratios·NGVT Institutional Holders
NGVT SEC Filings & Documents
Ingevity Corporation (NGVT) SEC filings — annual & quarterly reports (10-K, 10-Q)
NGVT Frequently Asked Questions
Ingevity Corporation (NGVT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Ingevity Corporation (NGVT) reported $1.21B in revenue for fiscal year 2025. This represents a 24% increase from $980.0M in 2013.
Ingevity Corporation (NGVT) saw revenue decline by 17.0% over the past year.
Ingevity Corporation (NGVT) reported a net loss of $127.8M for fiscal year 2025.
Dividend & Returns
Ingevity Corporation (NGVT) has a return on equity (ROE) of -148.6%. Negative ROE indicates the company is unprofitable.
Ingevity Corporation (NGVT) generated $245.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.